
6 Must-Try Indian Whisky Brands For Curious Enthusiasts
getty
When most whisky lovers picture the global map of great distilling regions, India probably doesn't come to mind—yet. But that's quickly changing.
Once known more for sheer volume than craftsmanship, India is now producing some of the most fascinating single malts and blends on the market. Brands like Amrut, Paul John, and Rampur are quietly building reputations as serious contenders, collecting international awards and turning heads in bars and collector circles from Mumbai to Manhattan.
India is also one of the world's largest whisky consumers, and for decades, most of what was labeled as "whisky" in the country wasn't actually whisky at all by global standards. Due to relaxed labeling laws, many popular Indian whiskies were made from molasses—technically rums—then blended with a small amount of grain spirit. They satisfied domestic demand but rarely left the subcontinent. That started to change in the early 2000s, when a few visionary producers set their sights beyond volume and toward quality.
With tropical aging conditions that accelerate maturation, native grains, and a growing appetite for innovation, Indian whisky is coming into its own. If you haven't yet explored what the country has to offer, here are six bottles that might change your perspective—and maybe your top shelf.
Amrut Fusion
Amrut
ABV: 50%Style: Single Malt
When Amrut released Fusion in 2009, it wasn't just making a statement—it was planting a flag. This was the first Indian whisky to get serious international attention, and for good reason. Fusion lives up to its name: it combines Indian barley grown in the foothills of the Himalayas with peated Scottish malt, creating a single malt that bridges two whiskey cultures.
Expect a rich aroma of dried fruit, toasted nuts, and a wisp of peat smoke. On the palate, it's bold and balanced, with flavors of tropical mango, cocoa, and spice, followed by a dry, oak-driven finish that lingers like a Scotch campfire with a mango lassi chaser.
Why Try It:
Fusion didn't just open the door for Indian whisky—it kicked it down. If you only try one bottle from the region, make it this one.
Rampur Asava
Rampur
ABV: 45%Style: Single Malt, Wine Cask Finished
Produced in the northern Indian state of Uttar Pradesh, Rampur is distilled by Radico Khaitan, one of India's oldest and largest spirits companies. But Asava is anything but old-school. This expression is aged in American oak before being finished in Indian Cabernet Sauvignon barrels—adding a truly local twist to an international format.
The result? A whisky with juicy notes of stewed plums, dark cherries, and cinnamon, layered with vanilla, oak, and a whisper of red wine tannin. It's lush, spicy, and almost jammy, but finishes dry and elegant.
Why Try It:
Cabernet cask finishing is rare even in traditional whiskey regions. Rampur's use of Indian wine barrels adds a uniquely regional character that sets Asava apart.
Paul John Brilliance
Paul John
ABV: 46%Style: Non-peated Single Malt
Crafted on the shores of Goa, Paul John Brilliance offers a sun-drenched expression of Indian whiskey. Made from Indian six-row barley and matured in ex-bourbon barrels, this non-peated malt captures the coastal warmth of its surroundings. It's aged relatively quickly thanks to the tropical climate, which intensifies its vanilla and honey-forward character.
The nose gives you sponge cake and orange blossom. On the palate, there's honeycomb, barley sugar, and a smooth finish with a gentle kick of pepper. It's sweet, light, and perfect for sipping on a warm evening—or for easing a bourbon drinker into the world of single malts.
Why Try It:
If Amrut Fusion is India's statement whisky, Paul John Brilliance is its easygoing charmer. A great introduction to Indian single malt for Scotch and bourbon fans alike.
Indri-Trini
Indri-Trini
ABV: 46%Style: Triple Cask Single Malt
Relatively new on the scene, Indri-Trini comes from the Piccadilly Distillery in the northern state of Haryana and is already turning heads with its ambition. The name 'Trini' refers to its triple cask maturation: ex-bourbon, French wine, and PX sherry barrels all contribute to its layered profile.
The nose is redolent of candied orange, dried fig, and sandalwood. Sip it, and you'll get a generous swirl of baking spice, vanilla fudge, and oak, with the PX sherry's raisin-like sweetness emerging late. It's both approachable and intriguing—like a well-dressed dinner guest with a backstory.
Why Try It:
Triple cask aging is a bold move for a relatively young distillery, and Indri pulls it off with confidence. It's an exciting sign of where Indian whiskey is headed next.
Godawan 01 'Rich & Rounded'
Godawan
ABV: 46%Style: Single Malt
Godawan (pronounced go-da-vun) is Diageo India's foray into sustainable, terroir-focused Indian whiskey. Distilled in Rajasthan and matured using a mix of Indian and European oak, this single malt incorporates native Indian botanicals like vetiver and rasna—a subtle nod to Ayurveda and local flavor.
The whisky opens with nutty richness, dried dates, and almond brittle, followed by an earthy undertone of sandalwood and spice. There's a warm desert quality to it—dry, slightly smoky, and complex.
Why Try It:
If terroir matters to you, Godawan is one of the only whiskys that leans all the way into Indian identity—grain, botanicals, and climate included.
Solan No. 1
Solan
ABV: 42.8%Style: Blended Malt
Before Amrut and Paul John put India on the global whisky map, there was Solan No. 1. First launched in the 1930s and produced by Mohan Meakin (of Old Monk rum fame), it's named after the town of Solan in the Himalayas, where Asia's oldest distillery still operates.
Solan No. 1 doesn't have the polish or punch of a modern single malt, but it offers gentle charm: light malt notes, soft caramel, a bit of floral grassiness, and an easy-drinking finish. It's the taste of nostalgia for many Indians and a time capsule in a bottle.
Why Try It:
This is the gateway to India's distilling past. Not the flashiest dram on the shelf, but a fascinating one nonetheless.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


NBC News
an hour ago
- NBC News
Ancient Buddha relics returned to India after $13 million auction is canceled
HONG KONG — A collection of ancient gems linked to Buddha's remains has been repatriated to India after authorities slammed their planned auction by Sotheby's in Hong Kong. 'A joyous day for our cultural heritage!' Indian Prime Minister Narendra Modi said Wednesday in a post on X. The Piprahwa Gems were sold to the Indian conglomerate Godrej Industries Group, which will put the dazzling collection 'on public display for years to come,' Sotheby's said in a statement Thursday. The auction house declined to reveal how much Godrej paid for the gems. 'Due to the confidential nature of private sales, the final sale price will not be disclosed,' Sotheby's told NBC News. The 334 gems had been expected to net upward of 100 million Hong Kong dollars ($12.9 million) at auction. The gemstones are part of a cache of more than 1,800 artifacts, mostly housed at the Indian Museum in Kolkata. Critics of the planned auction of the gems, which British colonial landowner William Claxton Peppé dug up on his northern Indian estate in 1898, said it was offensive to the world's 500 million Buddhists and a violation of Indian and international law and United Nations conventions. Many Buddhists believe the gemstones, named after the town in what is now the Indian state of Uttar Pradesh, where they were buried in a stupa, or funerary monument, around 200 to 240 B.C., are imbued with the presence of Buddha, on top of whose cremated remains the gemstones were said to be enshrined. 'It would make every Indian proud that the sacred Piprahwa relics of Bhagwan Buddha have come home after 127 long years,' Modi said, referring to Buddha as a god in Hindi. 'These sacred relics highlight India's close association with Bhagwan Buddha and his noble teachings,' he added. Sotetheby's postponed the planned auction of the gems in May after the Indian government threatened legal action and demanded their repatriation. The Indian government said at the time that Peppé's great-grandson, Chris Peppé, a TV director and film editor based in Los Angeles, lacked the authority to sell the gems. New Delhi also accused Sotheby's of 'participating in continued colonial exploitation' by facilitating the sale and said that the gems must be returned to India if Peppé no longer wished to be their custodian. 'I hope they will go to someone who really values them,' Peppé wrote in a February piece for Sotheby's accompanying the auction catalogue. They were put on public exhibition in Hong Kong in the days leading up to the auction in three glass cases, containing shimmering penny-sized silver and gold-leaf stars embossed with symbols. They also include pearls, beads and flowers cut from precious stones, including amethyst, topaz, garnet, coral and crystal. Sotheby's later announced the auction had been postponed 'with the agreement of the consignors,' three descendants of the British colonial landowner who excavated them. On Thursday, the auction house said it had 'facilitated the return' of the gems to India, thanking the Peppé family. 'This completes our active search over the past two months to identify the best possible custodian for the Gems,' Sotheby's said.


Business Upturn
2 hours ago
- Business Upturn
Why Dr. Reddy's shares are down nearly 2% today? Explained
By Aditya Bhagchandani Published on July 31, 2025, 09:44 IST Shares of Dr. Reddy's Laboratories Ltd dropped nearly 2% to ₹1,269.70 in early trade on Wednesday, reacting sharply to the overnight announcement by former U.S. President Donald Trump regarding the imposition of 25% tariffs on Indian exports to the United States. The move includes a yet-unspecified penalty for India's continued energy and defense dealings with Russia. The stock was among the worst-hit in the pharmaceutical space as investors digested the potential impact on generic drug exports, which constitute a major portion of India's pharmaceutical trade with the U.S. Pharma Exports at Risk? The United States is a critical market for Indian drugmakers. In fact, Dr. Reddy's derives 46% of its revenue from the U.S., making it highly sensitive to any changes in trade policy. While pharmaceuticals are currently exempt from the reciprocal tariff list (announced in April), officials from the White House confirmed to CNBC-TV18 that these exemptions may soon be lifted. The Department of Commerce's Section 232 investigation into Indian generic drug exports has now concluded, and according to Trump's latest statement, tariffs on pharma 'are coming soon.' Currently, India pays zero tariffs on generic drug exports to the U.S. If the proposed 25% tariff is applied to this sector, Indian companies may have to choose between: Passing the cost onto U.S. consumers , making Indian generics less price-competitive Reevaluating U.S. portfolios , withdrawing lower-margin or loss-making products Manufacturing in the U.S., which may offer no cost advantage for generics Broader Impact Across the Pharma Space Besides Dr. Reddy's, stocks likely to remain under pressure include: Sun Pharma (33% U.S. exposure) Aurobindo Pharma (45%) Gland Pharma (53%) Divi's Laboratories Cipla, Lupin, and Biocon Who Might Buck the Trend? Pharma firms and healthcare providers with a domestic business focus or minimal U.S. exposure may remain resilient: Ajanta Pharma, Eris Lifesciences, Torrent Pharma Apollo Hospitals, Fortis Healthcare, Aster DM Diagnostics players like Dr. Lal Pathlabs, Metropolis Final Word Though Indian pharma exports are not yet officially included in the tariff list, Trump's statements have created uncertainty for the sector. Until there is clarity from the U.S. Trade Representative or India's Commerce Ministry, investor sentiment around high U.S.-exposed pharma names may remain volatile. Ahmedabad Plane Crash Aditya Bhagchandani serves as the Senior Editor and Writer at Business Upturn, where he leads coverage across the Business, Finance, Corporate, and Stock Market segments. With a keen eye for detail and a commitment to journalistic integrity, he not only contributes insightful articles but also oversees editorial direction for the reporting team.


Business Upturn
2 hours ago
- Business Upturn
Gokaldas Exports crashes 6% after Trump's 25% tariff announcement on India
By Aditya Bhagchandani Published on July 31, 2025, 09:55 IST Shares of Gokaldas Exports Ltd tanked 6.2% to ₹834.90 on Wednesday, July 31, following U.S. President Donald Trump's announcement of a 25% tariff on Indian exports starting August 1. The steep drop follows a broader sell-off in Indian textile exporters with high U.S. revenue exposure. The announcement, which also included a penalty on India for purchasing Russian oil, triggered a decline across key players in the textile space. Alongside Gokaldas, stocks of Welspun Living, Indo Count Industries, and Pearl Global fell by up to 7%. U.S. Market Exposure Driving the Sell-Off: Gokaldas Exports: ~70% of revenue from U.S. ~70% of revenue from U.S. Indo Count Industries: ~70% U.S. exposure ~70% U.S. exposure Welspun Living: ~65% ~65% Pearl Global: ~50% ~50% Arvind Ltd: ~30% ~30% KPR Mill: ~21% The textile sector is under pressure as the new tariffs would push total duty costs for Indian apparel exporters to well over 30%, considering existing U.S. duties of 15–18% on such products. Sivaramakrishnan Ganapathi, Managing Director of Gokaldas Exports, earlier stated that price hikes to offset tariffs may impact demand in the U.S. market. India currently holds a 6% share of the U.S. readymade garment import market, compared to 19% for Vietnam and 9% for Bangladesh. With Vietnam agreeing to a 20% tariff and Bangladesh already facing a 35% duty, India's 25% rate places it at a competitive disadvantage. Analysts warn of potential order slowdowns and pricing pressure in the coming quarters for export-heavy Indian garment companies. Ahmedabad Plane Crash Aditya Bhagchandani serves as the Senior Editor and Writer at Business Upturn, where he leads coverage across the Business, Finance, Corporate, and Stock Market segments. With a keen eye for detail and a commitment to journalistic integrity, he not only contributes insightful articles but also oversees editorial direction for the reporting team.